User profiles for Leonardo V. Riella

Leonardo V. Riella

Medical Director of Kidney Transplantation, Massachusetts General Hospital, Harvard …
Verified email at mgh.harvard.edu
Cited by 6961

COVID‐19 and kidney transplantation: results from the TANGO International Transplant Consortium

…, N Agrawal, H Patel, E Akalin, LV Riella - American Journal of …, 2020 - Wiley Online Library
Kidney transplant recipients may be at a high risk of developing critical coronavirus disease
2019 (COVID‐19) illness due to chronic immunosuppression and comorbidities. We …

[HTML][HTML] Role of the PD-1 pathway in the immune response

LV Riella, AM Paterson, AH Sharpe… - American Journal of …, 2012 - Elsevier
Understanding immunoregulatory mechanisms is essential for the development of novel
interventions to improve long-term allograft survival. Programmed death 1 (PD-1) and its ligands…

Tixagevimab/cilgavimab pre‐exposure prophylaxis is associated with lower breakthrough infection risk in vaccinated solid organ transplant recipients during the …

…, M Cote, E Bethea, J Azzi, LV Riella - American Journal of …, 2022 - Wiley Online Library
The neutralizing monoclonal antibody combination of tixagevimab/cilgavimab has been shown
to reduce the risk of SARS‐CoV‐2 infection in unvaccinated individuals during the Alpha (…

[HTML][HTML] Remodeling of the immune response with aging: immunosenescence and its potential impact on COVID-19 immune response

…, SF Perazzio, J Azzi, P Cravedi, LV Riella - Frontiers in …, 2020 - frontiersin.org
Elderly individuals are the most susceptible to an aggressive form of coronavirus disease (COVID-19),
caused by SARS-CoV-2. The remodeling of immune response that is observed …

Discovery of autoantibodies targeting nephrin in minimal change disease supports a novel autoimmune etiology

…, SS Waikar, A Chandraker, LV Riella… - Journal of the …, 2022 - journals.lww.com
Background Failure of the glomerular filtration barrier, primarily by loss of slit diaphragm
architecture, underlies nephrotic syndrome in minimal change disease. The etiology remains …

COVID-19 in kidney transplant recipients

…, A Degli Antoni, L Peruzzi, LV Riella… - American Journal of …, 2020 - amjtransplant.org
An outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that began
in Wuhan, China, has spread rapidly and has already taken on pandemic proportions. 1 After …

The programmed death-1 ligand 1: B7-1 pathway restrains diabetogenic effector T cells in vivo

…, KE Brown, ME Keir, VK Vanguri, LV Riella… - The Journal of …, 2011 - journals.aai.org
Programmed death-1 ligand 1 (PD-L1) is a coinhibitory molecule that negatively regulates
multiple tolerance checkpoints. In the NOD mouse model, PD-L1 regulates the development …

The link between the PDL1 costimulatory pathway and Th17 in fetomaternal tolerance

F D'Addio, LV Riella, BG Mfarrej, L Chabtini… - The Journal of …, 2011 - journals.aai.org
Fetomaternal tolerance has been shown to depend both on regulatory T cells (Tregs) and
negative signals from the PD1–PDL1 costimulatory pathway. More recently, IL-17–producing T …

[HTML][HTML] COVID-19 and the kidneys: an update

C Benedetti, M Waldman, G Zaza, LV Riella… - Frontiers in …, 2020 - frontiersin.org
The new coronavirus disease 2019 (COVID-19) has become a world health emergency.
The disease predominantly effects individuals between 30 and 79 years of age with 81% of …

A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant

…, CD Schmults, GJ Hanna, B Sprangers, LV Riella… - Kidney international, 2021 - Elsevier
Immune checkpoint inhibitors (ICIs) are widely used for various malignancies. However, their
safety and efficacy in patients with a kidney transplant have not been defined. To delineate …